Drug Interactions and Management

Contraindications and Precautions

The American College of Cardiology recommends avoiding concurrent use of potassium-sparing diuretics with potassium supplements, other potassium-sparing diuretics, ACE inhibitors or ARBs, NSAIDs, and potent CYP3A4 inhibitors to prevent potential adverse interactions 1
Spironolactone is contraindicated in pregnancy due to potential feminization of male fetuses, and should be discontinued if pregnancy is planned, as advised by the American Academy of Dermatology and the American College of Cardiology 2, 3, 4
The American College of Cardiology advises avoiding concurrent medications that increase hyperkalemia risk, including potassium supplements, ACE inhibitors or ARBs, and NSAIDs 4

Routine potassium monitoring is unnecessary in young, healthy women without risk factors, but may be necessary for older patients or those with comorbidities, as recommended by the American Academy of Dermatology 2
The American College of Cardiology recommends checking electrolytes and renal function at 1 week, 1 month, and then every 3 months, with more frequent monitoring if dose is increased or if patient develops dehydration causes 4
Serum potassium levels should be monitored, as levels exceeding 5.5 mEq/L are a concern, according to the American College of Cardiology 4
Patients should avoid high-potassium foods, such as low-sodium processed foods and coconut water, when taking spironolactone, as advised by the American Academy of Dermatology 2

Common adverse effects of spironolactone include:
Side Effect Frequency
Menstrual irregularities 15-30%
Diuresis 29%
Breast tenderness 3-5%
Dizziness 3-4%
Nausea 2-4%
Polyuria 1-2%
2, 3, 5
The risk of menstrual irregularities increases significantly with higher doses, with a relative risk of 4.12 for women taking 200mg/day compared to lower doses, as reported by 3
High doses of androgen receptor antagonists may increase the risk of gynecomastia development in men, as demonstrated in a Japanese study where treatment was prematurely discontinued due to this effect 2

Multiple large studies have found no association between spironolactone use and breast cancer, as reported by the American Academy of Dermatology 2
A systematic review of 4.5 million individuals showed no increased risk of breast, ovarian, bladder, kidney, gastric, or esophageal cancer with spironolactone use, and spironolactone use is actually associated with decreased prostate cancer risk (RR 0.79; 95% CI 0.68-0.90) 5

Spironolactone is effective for hormonal acne patterns in women, with 66-85% of women experiencing significant improvement or complete clearance of acne, as supported by the American Academy of Dermatology 5, 2, 3
Treatment with spironolactone 100-150 mg daily resulted in improvement in 85% of patients with hidradenitis suppurativa-related hair loss, with complete remission achieved in 55% of patients with mild to moderate disease, according to the American Academy of Dermatology 6
Long-term use of spironolactone appears safe, with studies following patients for up to 8 years without serious adverse effects, as reported by 5

The recommended starting dose of spironolactone is 50-100 mg daily, with potential side effects including diuresis (29%), breast tenderness (17%), fatigue, headache, and dizziness, as advised by the American Academy of Dermatology 2
The typical dosage for hair loss treatment is 50-200 mg daily, aiming to bring testosterone levels to <50 ng/dL, as suggested by the Endocrine Society 7